Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Review and Preview01:10

Review and Preview

8.3K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.3K
Review and Preview01:13

Review and Preview

10.9K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
10.9K
What are Lipids?01:38

What are Lipids?

219.6K
Overview
219.6K
What are Lipids?01:31

What are Lipids?

10.9K
Lipids function as structural components of cellular membranes, in addition to acting as energy reservoirs and signaling molecules. They are thus crucial to all living organisms.  The three biologically important classes of lipids are triglycerides, phospholipids, and steroids.
Non-Polar and Hydrophobic Characteristics of Lipids
Lipids are a structurally and functionally diverse group of hydrocarbons—compounds consisting of carbon and hydrogen atoms. The carbon-carbon and...
10.9K
Lipid Digestion01:06

Lipid Digestion

99.0K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
99.0K
Structure of Lipids03:38

Structure of Lipids

98.5K
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
98.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.

Atherosclerosis·2017
Same author

Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study.

Nutrition (Burbank, Los Angeles County, Calif.)·2017
Same author

A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience.

Journal of clinical lipidology·2017
Same author

The Upregulation of Integrin α<sub>D</sub>β<sub>2</sub> (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis.

Journal of immunology (Baltimore, Md. : 1950)·2017
Same author

Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia.

Nature reviews. Cardiology·2017
Same author

Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs.

Circulation·2017

Related Experiment Video

Updated: Jan 25, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.5K

Poststatin Lipid Therapeutics: A Review.

Xiaoming Jia1, Patrick Lorenz1, Christie M Ballantyne1

  • 1BAYLOR COLLEGE OF MEDICINE, HOUSTON, TEXAS.

Methodist Debakey Cardiovascular Journal
|May 4, 2019
PubMed
Summary

Low-density lipoprotein cholesterol (LDL-C) is a key risk for cardiovascular disease. Nonstatin therapies like ezetimibe and PCSK9 inhibitors offer effective alternatives for patients not reaching LDL-C goals with statins.

Keywords:
LDL cholesterolPCSK9atherosclerosisezetimibenonstatin therapy

More Related Videos

Determination of Total Lipid and Lipid Classes in Marine Samples
14:59

Determination of Total Lipid and Lipid Classes in Marine Samples

Published on: December 11, 2021

5.3K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

11.1K

Related Experiment Videos

Last Updated: Jan 25, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.5K
Determination of Total Lipid and Lipid Classes in Marine Samples
14:59

Determination of Total Lipid and Lipid Classes in Marine Samples

Published on: December 11, 2021

5.3K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

11.1K

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Elevated low-density lipoprotein cholesterol (LDL-C) is a primary driver of atherosclerotic cardiovascular disease (ASCVD).
  • Statins are the standard first-line treatment for hypercholesterolemia and ASCVD risk reduction.
  • A significant patient subset experiences inadequate LDL-C lowering or statin intolerance due to adverse effects.

Purpose of the Study:

  • To review current non-statin therapeutic options for LDL-C management.
  • To explore emerging novel therapies for further reducing LDL-C and ASCVD risk.
  • To provide an overview of advanced treatment strategies beyond statin monotherapy.

Main Methods:

  • Literature review of recent cardiovascular outcome trials.
  • Analysis of efficacy data for non-statin agents including ezetimibe and PCSK9 inhibitors.
  • Exploration of ongoing clinical trials for novel lipid-lowering drugs.

Main Results:

  • Ezetimibe and PCSK9 inhibitors have proven effective in significantly reducing LDL-C levels.
  • These non-statin therapies demonstrate substantial reductions in ASCVD risk in clinical trials.
  • Several novel therapeutic targets and agents are under investigation for future clinical application.

Conclusions:

  • Non-statin therapies are crucial for achieving LDL-C targets in statin-intolerant or statin-resistant patients.
  • These agents offer significant ASCVD risk reduction, complementing statin therapy.
  • The pipeline of novel lipid-lowering therapies holds promise for further advancing cardiovascular disease prevention.